| |
Department
of Pathology and Early Detection Laboratory (GRS, LT, DJV), Peter MacCallum
Cancer Institute, East Melbourne, Victoria, Department of Biochemistry (RB,
AC), University of Sydney, New South Wales, and Department of Pathology
(DJV), University of Melbourne, Parkville, Victoria, Australia |
| |
The P2Y family of purinergic receptors are members of the G-protein-coupled
receptor superfamily. The P2Y6 subtype is expressed at particularly high
levels in the placenta, suggesting that P2Y6 plays an important role in
placental function. However, the cellular localization of P2Y6 within
the placenta is unknown. This study examined the expression of P2Y6 in
first-trimester and full-term placental tissues, as well as examples of
gestational trophoblastic disease, by Northern blot analysis and in situ
hybridization. P2Y6 message was present at similar levels in first-trimester
and full-term placenta, and in situ hybridization revealed that message
was most abundant in the cytotrophoblast of the villi and chorionic plate
at both gestational stages. The syncytiotrophoblast harbored lower levels
of P2Y6 in first-trimester placenta, and by full-term, the syncytiotrophoblast
only focally expressed P2Y6 transcripts. Neither the intermediate trophoblast
nor nontrophoblastic elements of the placenta expressed P2Y6. Molar disease
expressed P2Y6 in the villous trophoblast but not in the proliferative
intermediate trophoblast, recapitulating the pattern of first-trimester
placenta. Neither choriocarcinoma nor the choriocarcinoma cell lines JEG-3
and JAr expressed P2Y6 transcript. These findings reveal that P2Y6 mRNA
production is highly characteristic of the epithelial-like cytotrophoblast
and syncytiotrophoblast, whereas expression is absent in the mesenchymal-like
intermediate trophoblast. Thus, P2Y6 may play an important role in trophoblastic
development, differentiation, and neoplasia.
|